Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

National Trends in Utilization and Outcomes of Intravenous Thrombolytic Treatment among Pediatric Patients with Acute Ischemic Stroke in United States
Cerebrovascular Disease and Interventional Neurology
(-)
009
Authors/Disclosures

PRESENTER
No disclosure on file
Seward B. Rutkove, MD, FAAN Dr. Rutkove has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Myolex, Inc. Dr. Rutkove has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neuorlogy . The institution of Dr. Rutkove has received research support from NIH. The institution of Dr. Rutkove has received research support from NASA. The institution of Dr. Rutkove has received research support from Blavatnik Family Foundation. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with NIH.
Abeer Alsalamah (Prince Sultan Military Medical City) No disclosure on file
Taqi T. Zafar, MD (SUNY Health Science Center, Upstate) No disclosure on file
Mohammad Owais, MD (Baptist Health) No disclosure on file
No disclosure on file
Gautam Sachdeva, MD No disclosure on file
Swaroop Pawar, MD (Duke University Medical Center) No disclosure on file
Syed I. Hussain, MD (Cleveland Clinic Abu Dhabi) Dr. Hussain has nothing to disclose.
Hamza I. Maqsood, MD (Dept of Neurology) Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.